Medicenna Therapeutics Corp (MDNAF)

$0.59 -0.01 (-2.15%)
Market Cap 50.05M
Revenue (ttm) 0.00
Net Income (ttm) -8.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 51,900
Avg Vol 128,934
Day's Range N/A - N/A
Shares Out 83.41M
Stochastic %K 7%
Beta 1.81
Analysts Strong Sell
Price Target $2.96

Company Profile

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15...

Industry: Biotechnology
Sector: Healthcare
Phone: 416 648 5555
Address:
2 Bloor Street West, Suite 903 7th Floor, Toronto, Canada
TraderBuckNKY
TraderBuckNKY Jun. 3 at 1:34 PM
$MDNAF well, it's something:... NEO-CYT positions MDNA11 in a frontline neoadjuvant melanoma setting, where immunotherapy before surgery may help generate deeper and more durable anti-tumor immune responses Up to 80 patients with locally advanced melanoma will be randomized in this Investigator-sponsored, multicenter Phase 1b NEO-CYT trial led by Professor Paolo A. Ascierto of the Istituto Nazionale Tumori Fondazione “G. Pascale” and sponsored by Fondazione Melanoma Onlus Together with the ongoing Phase 1/2 ABILITY-1 expansion cohorts in the 2L/3L Tx setting, NEO-CYT supports a broader clinical strategy to evaluate MDNA11 across select tumor types and multiple stages of disease, expanding future commercial opportunities MDNA11 clinical data updates from the ABILITY-1 and NEO-CYT trials are anticipated in H2 2026.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Jun. 3 at 11:06 AM
$MDNAF Nothing much to see here folks…. https://ir.medicenna.com/news-releases/news-release-details/medicennas-mdna11-potential-earlier-line-melanoma-setting
0 · Reply
rudazur2
rudazur2 Jun. 1 at 5:50 PM
$MDNAF
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 29 at 4:27 PM
$MDNAF blah…. They aren’t even pumping ASCO currently and it’s on now!
3 · Reply
Brocseg3
Brocseg3 May. 28 at 1:14 PM
$MDNAF https://ir.medicenna.com/news-releases/news-release-details/medicenna-announces-closing-public-offering-units-raising-cdn444
0 · Reply
Biotech_Beast
Biotech_Beast May. 28 at 12:48 PM
$MDNAF I'm long this name. Merchant has done it again I think. Making sure the company has the money to make it to Neo-Cyt results (which gives multiple shots on goal due to testing multiple regimes) and getting into the clinic with 113. Also making it to the H2 update from MDNA11 (2L/3L work) and beyond.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 27 at 11:10 AM
$MDNAF we find out today how much we’re giving away I guess?
0 · Reply
Lytnup
Lytnup May. 22 at 10:28 PM
$MDNAF More light reading for the long weekend; many thanks to those who have made the ultimate sacrifice on our behalf. https://open.substack.com/pub/davidbakke/p/mdna11-strategic-positioning-in-the?r=10wt7d&utm_medium=ios
1 · Reply
_Osmium
_Osmium May. 22 at 5:39 PM
$MDNAF With the PR this morning, we can get a more accurate number for amount raised: 10,000,000 units at $ .50CAN = $3.6M USD minus fees so let's say $3.5M USD maximum. Each Unit comes with a .5 share warrant attached at an exercise price of $ .65 CAN ($.47USD) is an additional 5,000,000 shares if fully exercised. 5,000,000 warrants at $.65CAN = $2.35M USD $3.5M +2.35M = $5.85M USD (approximately) $5.85M USD raised if fully subscribed and IF warrants are exercised. Let me state: This is the BARE minimum Fahar Merchant could do to keep the lights on. This is both financially responsible by management and tight rope walking. There is no margin for error. It is apparent management must think they have something and confident it will manifest before this cash runs out. All in my opinion. Please remember those who have and still serve in our military.
1 · Reply
R_Jamie_Langa
R_Jamie_Langa May. 22 at 2:10 PM
$MDNAF How much runway does this offering give the company? I read that this is 3 to 5 million dollars (is that correct?), which wouldn't seem to buy that much more time.
1 · Reply
Latest News on MDNAF
No data available.
TraderBuckNKY
TraderBuckNKY Jun. 3 at 1:34 PM
$MDNAF well, it's something:... NEO-CYT positions MDNA11 in a frontline neoadjuvant melanoma setting, where immunotherapy before surgery may help generate deeper and more durable anti-tumor immune responses Up to 80 patients with locally advanced melanoma will be randomized in this Investigator-sponsored, multicenter Phase 1b NEO-CYT trial led by Professor Paolo A. Ascierto of the Istituto Nazionale Tumori Fondazione “G. Pascale” and sponsored by Fondazione Melanoma Onlus Together with the ongoing Phase 1/2 ABILITY-1 expansion cohorts in the 2L/3L Tx setting, NEO-CYT supports a broader clinical strategy to evaluate MDNA11 across select tumor types and multiple stages of disease, expanding future commercial opportunities MDNA11 clinical data updates from the ABILITY-1 and NEO-CYT trials are anticipated in H2 2026.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Jun. 3 at 11:06 AM
$MDNAF Nothing much to see here folks…. https://ir.medicenna.com/news-releases/news-release-details/medicennas-mdna11-potential-earlier-line-melanoma-setting
0 · Reply
rudazur2
rudazur2 Jun. 1 at 5:50 PM
$MDNAF
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 29 at 4:27 PM
$MDNAF blah…. They aren’t even pumping ASCO currently and it’s on now!
3 · Reply
Brocseg3
Brocseg3 May. 28 at 1:14 PM
$MDNAF https://ir.medicenna.com/news-releases/news-release-details/medicenna-announces-closing-public-offering-units-raising-cdn444
0 · Reply
Biotech_Beast
Biotech_Beast May. 28 at 12:48 PM
$MDNAF I'm long this name. Merchant has done it again I think. Making sure the company has the money to make it to Neo-Cyt results (which gives multiple shots on goal due to testing multiple regimes) and getting into the clinic with 113. Also making it to the H2 update from MDNA11 (2L/3L work) and beyond.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 27 at 11:10 AM
$MDNAF we find out today how much we’re giving away I guess?
0 · Reply
Lytnup
Lytnup May. 22 at 10:28 PM
$MDNAF More light reading for the long weekend; many thanks to those who have made the ultimate sacrifice on our behalf. https://open.substack.com/pub/davidbakke/p/mdna11-strategic-positioning-in-the?r=10wt7d&utm_medium=ios
1 · Reply
_Osmium
_Osmium May. 22 at 5:39 PM
$MDNAF With the PR this morning, we can get a more accurate number for amount raised: 10,000,000 units at $ .50CAN = $3.6M USD minus fees so let's say $3.5M USD maximum. Each Unit comes with a .5 share warrant attached at an exercise price of $ .65 CAN ($.47USD) is an additional 5,000,000 shares if fully exercised. 5,000,000 warrants at $.65CAN = $2.35M USD $3.5M +2.35M = $5.85M USD (approximately) $5.85M USD raised if fully subscribed and IF warrants are exercised. Let me state: This is the BARE minimum Fahar Merchant could do to keep the lights on. This is both financially responsible by management and tight rope walking. There is no margin for error. It is apparent management must think they have something and confident it will manifest before this cash runs out. All in my opinion. Please remember those who have and still serve in our military.
1 · Reply
R_Jamie_Langa
R_Jamie_Langa May. 22 at 2:10 PM
$MDNAF How much runway does this offering give the company? I read that this is 3 to 5 million dollars (is that correct?), which wouldn't seem to buy that much more time.
1 · Reply
rudazur2
rudazur2 May. 22 at 1:46 PM
$MDNAF I know I will regret but I just add 10k more share The raise was not that bad
1 · Reply
boomshiva
boomshiva May. 22 at 1:38 PM
$MDNAF Let's see how she responds once the Canadians wake up.
0 · Reply
NewbJackCity
NewbJackCity May. 22 at 12:41 PM
$MDNAF if it is ~20m shares that’s about 24% dilution. OS is 83.42M. OS is a lot lower than I thought here.
2 · Reply
rudazur2
rudazur2 May. 22 at 12:19 PM
$MDNAF 30% dilution now we need to know until when they can survive without raising again cash
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 22 at 11:50 AM
$MDNAF oops didn’t read the whole thing! 24 million shares more for the equity investment
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 22 at 11:09 AM
$MDNAF Watering us down by 15 million shares… not bad but not a lot of $$ to work with either…let’s hope to f’ that they got good news in the hopper or expecting a lot from Neo-Cyt!! https://ir.medicenna.com/news-releases/news-release-details/medicenna-announces-filing-its-prospectus-supplement-and
0 · Reply
Biosectors
Biosectors May. 22 at 2:26 AM
$MDNAF Thanks for the update. 6 weeks cycle followed by 7 weeks of post surgery observations in neo cyt hope we can get an update end of June about CD8 and ctDNA any vascular leaks noticed cytokine levels etc so there is some hope in this trial for us. I am still holding since 2022 and tempted to add now to Average down and pray ability one update and 113 filing will give us some breathing room for investing with so much confidence. Very good pipeline and platform but surprised no one showing interest to even take mdna55 gbm phsse3. Was expecting big guys to go after 113 but still optimistic after this dilution too. Hope RA and insiders bought this round too if not it’s a bit disappointing.
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag May. 21 at 10:38 PM
$MDNAF abstract for ASCO out https://www.asco.org/abstracts-presentations/266745
1 · Reply
rudazur2
rudazur2 May. 20 at 10:13 PM
$MDNAF if they raise 10M we get 50% dilution 😂😂 I don't see a world where we are not f*cked
1 · Reply
Pilotboy1985
Pilotboy1985 May. 20 at 5:21 PM
$MDNAF new 52-week lows each day this week. Can someone please talk me out of buying more and averaging down??? Please.
2 · Reply
ablor
ablor May. 20 at 4:04 PM
$MDNAF Does it say anywhere how many "units" are expected to be sold? Size of offering/how much it's going to bring in?
1 · Reply
bobwut12
bobwut12 May. 20 at 9:36 AM
$MDNAF On a scale from Sellas to Briacell investors, how screwed are we Medicenna investors?
1 · Reply